drugset / Trial / NCT03971500

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

NCT03971500 ↗

Active not recruiting 3710 enrolled Nanjing First Hospital, Nanjing Medical University
RandomizedParallel-groupTriple-blindTreatment

Summary

Prospective, multicenter, randomized, double-blind, placebo-controlled trials.

Timeline

Start
2019-08-20
Primary completion
2023-10-27
Completion
2026-10-30

Outcome

Met primary endpoint

paper absolute difference -0·1% [95% CI -1·4% to 1·2%]; HR 0·98 [95% CI 0·69 to 1·39]; pnon-inferiority<0·0001 PMID 38599220 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg Oral
Background Ticagrelor Small molecule 90 mg Oral